167 related articles for article (PubMed ID: 9001725)
41. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice.
Fornai F; Bassi L; Torracca MT; Scalori V; Corsini GU
Eur J Pharmacol; 1995 Sep; 283(1-3):99-102. PubMed ID: 7498327
[TBL] [Abstract][Full Text] [Related]
42. Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.
Gilad GM; Gilad VH; Finberg JP; Rabey JM
Neurochem Res; 2005; 30(6-7):713-9. PubMed ID: 16187208
[TBL] [Abstract][Full Text] [Related]
43. Effect of intraventricular injection of 1-methyl-4-phenylpyridinium: protection by acetyl-L-carnitine.
Steffen V; Santiago M; de la Cruz CP; Revilla E; Machado A; Cano J
Hum Exp Toxicol; 1995 Nov; 14(11):865-71. PubMed ID: 8588946
[TBL] [Abstract][Full Text] [Related]
44. Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):129-32. PubMed ID: 3258433
[TBL] [Abstract][Full Text] [Related]
45. In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Thomas B; Muralikrishnan D; Mohanakumar KP
Brain Res; 2000 Jan; 852(1):221-4. PubMed ID: 10661517
[TBL] [Abstract][Full Text] [Related]
46. Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
Plangár I; Zádori D; Szalárdy L; Vécsei L; Klivényi P
Ideggyogy Sz; 2013 Nov; 66(11-12):407-14. PubMed ID: 24555241
[TBL] [Abstract][Full Text] [Related]
47. Modulatory effects of testosterone on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Dluzen D; Jain R; Liu B
J Neurochem; 1994 Jan; 62(1):94-101. PubMed ID: 8263548
[TBL] [Abstract][Full Text] [Related]
48. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
49. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Lau YS; Trobough KL; Crampton JM; Wilson JA
Gen Pharmacol; 1990; 21(2):181-7. PubMed ID: 2332138
[TBL] [Abstract][Full Text] [Related]
50. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) effects on enkephalinergic neurons in various regions of mouse brain.
Mitsuo K; Cosi C; Harvey-White JD; Schwartz JP
Neurochem Int; 1993 Feb; 22(2):175-82. PubMed ID: 8439770
[TBL] [Abstract][Full Text] [Related]
51. Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart.
Wallace RA; Boldry R; Schmittgen T; Miller D; Uretsky N
Life Sci; 1984 Jul; 35(3):285-91. PubMed ID: 6146909
[TBL] [Abstract][Full Text] [Related]
52. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
[TBL] [Abstract][Full Text] [Related]
53. Systemic lipopolysaccharide plus MPTP as a model of dopamine loss and gait instability in C57Bl/6J mice.
Byler SL; Boehm GW; Karp JD; Kohman RA; Tarr AJ; Schallert T; Barth TM
Behav Brain Res; 2009 Mar; 198(2):434-9. PubMed ID: 19070633
[TBL] [Abstract][Full Text] [Related]
54. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
Alam G; Edler M; Burchfield S; Richardson JR
Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
[TBL] [Abstract][Full Text] [Related]
55. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
McGrew DM; Irwin I; Langston JW
Neurotoxicology; 2000 Jun; 21(3):309-12. PubMed ID: 10894120
[TBL] [Abstract][Full Text] [Related]
56. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
Spooren WP; Vassout A; Waldmeier P; Gentsch C
Eur J Pharmacol; 1998 Jul; 353(1):1-4. PubMed ID: 9721033
[TBL] [Abstract][Full Text] [Related]
57. Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Schneider JS
Neuropharmacology; 1992 Feb; 31(2):185-92. PubMed ID: 1553028
[TBL] [Abstract][Full Text] [Related]
58. Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
Donnan GA; Willis GL; Kaczmarczyk SJ; Rowe P
J Neurol Sci; 1987 Feb; 77(2-3):185-91. PubMed ID: 3493329
[TBL] [Abstract][Full Text] [Related]
59. Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
Castro AA; Ghisoni K; Latini A; Quevedo J; Tasca CI; Prediger RD
Behav Brain Res; 2012 Apr; 229(1):208-15. PubMed ID: 22266923
[TBL] [Abstract][Full Text] [Related]
60. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice.
Cosi C; Colpaert F; Koek W; Degryse A; Marien M
Brain Res; 1996 Aug; 729(2):264-9. PubMed ID: 8876997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
